Females with von Willebrand disease: 72 years as the silent majority

Haemophilia

Volumn 4, Issue 4, 1998, Pages 665-676

  Kouides, P A ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Desmopressin; Factor VIIIC level; Menorrhagia; Obstetrical and gynaecological complications; Post partum bleeding; von Willebrand disease

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8C; DANAZOL; DESMOPRESSIN; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; VON WILLEBRAND FACTOR;

ANEMIA; BLOOD TRANSFUSION; CHILDBIRTH; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; GENDER; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INTRANASAL DRUG ADMINISTRATION; MENORRHAGIA; MENSTRUATION; MORBIDITY; ORAL DRUG ADMINISTRATION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; VON WILLEBRAND DISEASE;

EID: 0031825529     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440665.x     Document Type: Conference Paper

References (111)

1. von Willebrand EA. Hereditar pseudohemofili. Finska Lakarsallskapets Handl 1926; 67: 7-112.
2. Murray EW, Lilllcrap D. von Willebrand disease: pathogenesis, classification, and management. Trans Med Rev 1996; 10: 93-110.
3. Shampo MA, Kyle RA. Erik von Willebrand - von Willebrand's disease. Mayo Clinic Proc 1996; 71: 1088.
4. Tolliss D. Who was von Willebrand? Nursing Times 1995; 91: 47.
5. Zhang ZP, Blomback M, Nyman D, Anvret M. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands. Proc Natl Acad Sci USA 1993; 90: 7937-40.
6. Weiss RM. Case presentation: a patient with von Willebrand disease with menorrhagia. Amer J Obstet Gynecol 1996; 175:Pt 2: 763-5.
7. Ahuja R, Kriplani A, Choudhary VP, Takkar D. von Willebrand disease: a rare cause of puberty menorrhagia. Aust NZ J Obstet Gynaecol 1995; 35: 337-8.
8. Evans PC. Obstetric and gynecologic patients with von Willebrand's disease. Obstet Gynecol 1971; 38: 37-43.
9. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Brit J Obstet Gynaecol 1991; 98: 909-18.
10. Noller KL, Bowie EJ, Kempers RD, Owen CA, Jr. Von Willebrand's disease in pregnancy. Obstet Gynecol 1973; 41: 865-72.
11. Quick AJ. Menstruation in hereditary bleeding disorders. Obstet Gynecol 1966; 28: 37-48.
12. Lusher JM, McMillan CW. Severe factor VIII and factor IX deficiency in females. Amer J Med 1978; 65: 637-48.
13. Foster PA. The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 784-90.
14. Federici AB, Mannucci PM. Actual management of von Willebrand disease: first report on 880 cases of the Italian registry of vWD. Blood 1997; 90:33a (abstract).
15. Sramek A, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders [see comments]. Arch Int Med 1995; 155: 1409-15.
16. van Eijkeren MA, Christiaens GC, Sixma JJ, Haspels AA. Menorrhagia: a review. Obstet Gynecol Survey 1989; 44: 421-9.
17. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Amer J Obstet Gynecol 1984; 149: 788-93.
18. Chimbira TH, Anderson AB, Turnbull AC. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol 1980; 87: 603-9.
19. Haynes PJ, Hodgson H, Anderson AB, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol 1977; 84: 763-8.
20. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966; 45: 320-51.
21. Wahlberg T, Blomback M, Hall P, Axelsson G. Application of indicators, predictors and diagnostic indices in coagulation disorders. 1. Evaluation of a self-administered questionnaire with binary questions. Meth Infor Med 1980; 19: 194-200.
22. Montgomery RR, Coller BS. von Willebrand Disease. In Hemostasis and Thrombosis: Basic Principles and Practice, Colman RW, Hirsh J, Marder VJ, et al. (eds.). Philadelphia: J.B. Lippincott, 1994; pp 134-68.
23. Kouides PA, Burkhart P, Phatak P, et al. Type I von Willebrand disease causes significant obstetric-gynecological morbidity. Blood 1997; 90: 32a (abstract).
24. van Eijkeren MA, Christiaens GC, Geuze JJ, Haspels AA, Sixma JJ. Morphology of menstrual hemostasis in essential menorrhagia. Lab Investigation 1991; 64: 284-94.
25. van Eijkeren MA, Christiaens GC, Haspels AA, Sixma JJ. Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy. Am J Obstet Gynecol 1990; 162: 1261-3.
26. Fraser IS, McCarron G, Markham R, Resta T, Watts A. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet Gynecol 1986; 68: 630-3.
27. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus "variants". Blood 1980; 56: 712-6.
28. DiPaola J, Federici AB, Sacchi E, et al. Low platelet alpha2betal in levels in patients with von Willebrand disease Type I represents an increased risk factor for bleeding. Blood 1997; 90: 27a (abstract).
29. Rose EH, Aledort LM. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Inter Med 1991; 114: 563-8.
30. Lethagen S, Ragnarson Tennvall G. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Ann Hematol 1993; 66: 257-60.
31. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996; 76: 692-6.
32. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-8.
33. Blomback M, Eneroth P, Andersson O, Anvret M. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992; 40: 117-20.
34. Blomback M, Eneroth P, Landgren BM, Lagerstrom M, Anderson O. On the intraindividual and gender variability of haemostatic components. Thromb Haemost 1992; 67: 70-5.
35. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr., Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
36. Sadler JE. 1995 Minutes of the von Willebrand Factor Subcommittee, International Society of Thrombosis and Hemostasis. Jerusalem, Israel, 1995 (pers comm).
37. Mannucci PM, Bloom AL, Larrieu MJ, Nilsson IM, West RR. Atherosclerosis and von Willebrand factor. 1. Prevalence of severe von Willebrand's disease in western Europe and Israel. Brit J Haematol 1984; 57: 163-9.
38. Claessens EA, Cowell CA. Acute adolescent menorrhagia. Amer J Obstet Gynecol 1981; 139: 277-80.
39. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
40. Kouides PA, Phatak P, Sham RL, et al. Adjusting the reference range of von Willebrand factor levels and factor VIIIc level in relation to the menstrual cycle. Blood 1997; 90: 32a (abstract).
41. Dilley A. Centers for Disease Control project of testing for von Willebrand disease in menorrhagia. Pers comm, 1997.
42. Wemer EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Ped 1993; 123: 893-8.
43. Fraser IS: Menorrhagia - a pragmatic approach to the understanding of causes and the need for investigations. Br J Obstet Gynaecol 1994; 101: (Suppl 11): 3-7.
44. Alperin JB. Estrogens and surgery in women with von Willebrand's disease. Am J Med 1982; 73: 367-71.
45. David JL, Gaspard UJ, Gillain D, Raskinet R, Lepot MR. Hemostasis profile in women taking low-dose oral contraceptives. Am J Obstet Gynecol 1990; 163: 420-3.
46. Mangal AK, Naiman SC. Oral contraceptives and von Willebrand's disease [letter]. Can Med Assoc J 1983; 128: 1274.
47. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss and iron deficiency. Acta Med Scand 1966; 180: 639-50.
48. Cohen BJ, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Survey 1980; 35: 597-618.
49. Beck EA, Limoni C. Subnormal plasma von Willebrand factor (ristocetin cofactor) and iron deficiency anaemia in menstruating women [letter]. Thromb Haemost 1996; 75: 693.
50. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. New Engl J Med 1993; 328: 856-60.
51. Fraser IS, Angsuwathana S, Mahmoud F, Yezerski S. Short and medium term outcomes after rollerball endometrial ablation for menorrhagia. Med J Aust 1993; 158: 454-7.
52. Coulter A. Managing menorrhagia with endometrial resection [see comments]. Lancet 1993; 341: 1185-6.
53. Lusher JM. Screening and diagnosis of coagulation disorders. Amer J Obstet Gynecol 1996; 175:Pt 2: 778-83.
54. Doherty L, Harper A, Russell M. Menorrhagia management options. Ulster Med J 1995; 64: 64-71.
55. Ruta DA, Garratt AM, Chadha YC, Flett GM, Hall MH, Russell IT. Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status? Quality Life Res 1995; 4: 33-40.
56. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1: 140-4.
57. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Pregnancy in von Willebrand's disease [letter; comment]. J Clin Pathol 1994; 47: 569-70.
58. Caldwell DC, Williamson RA, Goldsmith JC. Hereditary coagulopathics in pregnancy. Clin Obstet Gynecol 1985; 28: 53-72.
59. Lipton RA, Ayromlool J, Coller BS. Severe von Willebrand's disease during labor and delivery. JAMA 1982; 248: 1355-7.
60. Hanna W, McCarroll D, McDonald T, Painter P, Tuller J, Chen J, Lange R. Variant von Willebrand's disease and pregnancy. Blood 1981; 58: 873-9.
61. Krishnamurthy M, Miotti AB. Von Willebrand's disease and pregnancy. Obstet Gynecol 1977; 49: 244-7.
62. Leone G, Moneta E, Paparatti G, Boni P. Letter: Von Willebrand's disease in pregnancy. New Engl J Med 1975; 293: 456.
63. Mannucci PM. Treatment of von Willebrand disease. J Int Med 1997; 242 (Suppl 740): 129-32.
64. Kasper CK, Hoag MS, Aggeler PM, Stone S: Blood clotting factors in pregnancy: Factor VIII concentrations in normal and AHF-deficient women. Obstet Gynecol 1964; 24: 242-7.
65. Sorosky J, Klatsky A, Norbert GF, Burchill RC. von Willebrand's disease complicating second trimester abortion. Obstet Gynecol 1980; 55: 253-4.
66. Punnonen R, Nyman D, Gronroos M, Ward CL. von Willebrand's disease and pregnancy. Acta Obstet Gynecol Scand 1981; 60: 507-9.
67. Cohen S, Daitch JS, Amar D, Goldiner PL. Epidural analgesia for labor and delivery in a patient with von Willebrand's disease. Regional Anesthesia 1989; 14: 95-7.
68. Kleiman SJ, Wiesel S, Tessler MJ. Patient-controlled analgesia (PCA) using fentanyl in a partunent with a platelet function abnormality. Can J Anaesth 1991; 38: 489-91.
69. Adashi EY. Lack of improvement in von Willebrand's disease during pregnancy [letter]. New Engl J Med 1980; 303: 1178.
70. Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282-5.
71. Chediak JR, Alban GM, Maxey B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Amer J Obstet Gynecol 1986; 155: 618-24.
72. Takahashi N. Studies on the pathophysiology and treatment of von Willebrand's disease VI. Variant von Willebrand's disease complicating placental previa. Thromb Res 1983; 31: 285-96.
73. Biggs R, Matthews JM. The treatment of hemorrhage in von Willebrand's disease and the blood levels of factor VIII (AHG). Br J Haematol 1963; 9: 203.
74. Larrieu MJ, Caen JP, Meyer D. Congenital bleeding disorders with long bleeding time and normal platelet count. H. von Willebrand's disease (report of thirty-seven patients). Am J Med 1968; 45: 354.
75. Watanabe T, Minakaini H, Sakata Y. Successful management of pregnancy in a patient with von Willebrand disease Normandy. Obstet Gynecol 1997; 89: 859.
76. Casonato A, Sartori MT, Bertomoro A, Fede T, Vasoin F, Girolami A. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. Blood Coag Fibrinol 1991; 2: 33-40.
77. Ieko M, Sakurama S, Sagawa A, Yoshikawa M, Satoh M, Yasukouchi T, Nakagawa S. Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers. Am J Hematol 1990; 35: 26-31.
78. Pareti FI, Federici AB, Cattaneo M, Mannucci PM. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa. Br J Haematol 1990; 75: 86-91.
79. Rick ME, Williams SB, Sacher RA, McKeown LP. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood 1987; 69: 786-9.
80. Siegbahn A, Odlind V, Hedner U, Venge P. Coagulation and fibrinolysis during the nortnal menstrual cycle. Upsala J Med Sci 1989; 94: 137-52.
81. Mandalaki T, Louizou C, Dimitriadou C, Symeonidis P. Variations in factor VIII during the menstrual cycle in normal women [letter]. New Engl J Med 1980; 302: 1093-4.
82. Werner EJ, Werner A, Gies L, et al. Variability of von Willebrand factor levels: a chronobiological study. Blood 1995; 87: 754a (abstract).
83. Blomback M. von Willebrand's disease in Scandinavia and on difficulties in diagnosing von Willebrand's disease type 1. Haemostasis 1992; 22: 236-44.
84. Cederblad G, Hahn L, Korsan-Bengtsen K, Pehrsson NG, Rybo G. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Haemostasis 1977; 6: 294-302.
85. Hahn L, Cederblad G, Rybo G, Pehrsson NG, Bengtsen KK. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss. Br J Obstet Gynaecol 1976; 83: 974-80.
86. Berge LN, Lyngmo V, Svensson B, Nordoy A. The bleeding time in women: an influence of the sex hormones? Acta Obstet Gynecol Scand 1993; 72: 423-7.
87. Suzuki S, Matsuno K, Kondoh M. Primary hemostasis during women's life cycle measured by Thrombostat 4000. Sem Thromb Hemost 1995; 21 (Suppl 2): 103-5.
88. Blomback M, Landgren BM, Stlemholm Y, Andersson O. The effect of progesterone on the haemostatic mechanism. Thromb Haemost 1997; 77: 105-8.
89. Blesing NE, Hambley H, McDonald GA. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J 1990; 66: 474-6.
90. Klein M, Barbe F, Kaminsky P, Duc M. [Disorders of hemostasis in dysthyroidism]. [Review] [French]. Pathol Biol 1993; 41: 268-75.
91. Coccia MR, Barnes HV. Hypothyroidism and acquired von Willebrand disease. J Adolesc Health 1991; 12: 152-4.
92. Aylesworth CA, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995; 50: 217-9.
93. Lethagen S, Ragnarson Tennvall G. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Ann Hematol 1993; 66: 257-60.
94. Seremetis SV, Aledort LM. Desmopressin nasal spray for hemophilia A and type I von Willebrand disease [letter]. Ann Int Med 1997; 126: 744-5.
95. Mannucci PM. Desmopresin (DDAVP) in the treatment of bleeding disorders - the first 20 years [Review]. Blood 1997; 90: 2515-21.
96. Kobrinsky N, Goldsmith J. Efficacy of stimate (desmopressin acetate) nasal spray, 1.5 ng/ml, for the treatment of menorrhagia in women with inherited bleeding disorders. Blood 1997; 90: 3186 (abstract).
97. Cohen A. Current practice programs of the management of von Willebrand disease. Pers comm, 1997.
98. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85: 977-82.
99. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexwnic acid [see comments]. BMJ 1996; 313: 579-82.
100. Ong YL, Hull DR, Mayne EE. Menorrhagia in von Willebrand disease successfully treated with a single daily dose tranexamic acid. Haemophilia 1998; 4: 63-5.
101. Chimbira TH, Cope E, Anderson AB, Bolton FG. The effect of danazol on menorrhagia, coagulation mechanisms, haematological indices and body weight. Br J Obstet Gynaecol 1979; 86: 46-50.
102. Fraser IS. Treatment of dysfunctional uterine bleeding with danazol. Aust NZ J Obstet Gynaecol 1985; 25: 224-6.
103. Shaw RW. Treating the patient with menorrhagia. Brit J Obstet Gynaecol 1994; 101 (Suppl 11): 1-2.
104. Anonymous. Guidelines for the diagnosis and management of von Willebrand disease. Haemophilia 1997; 3 (Suppl 2): 4-8.
105. Highain JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
106. Chullapram T, Song JY, Fraser IS. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation. Obstet Gynecol 1996; 88: 71-6.
107. Erian J. Endometrial ablation in the treatment of menorrhagia. Brit J Obstet Gynaecol 1994; 101 (Suppl 11): 19-22.
108. Ito M, Yoshimura K, Toyoda N, Wada H. Pregnancy and delivery in patients with von Willebrand's disease. J Obstet Gynaecol Res 1997; 23: 3743.
109. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R. Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force. J Clin Pathol 1994; 47: 100-8.
110. Weinbaum PJ, Cassidy SB, Campbell WA, Rickles FR, Vintzileos AM, Nochimson DJ, Tsipouras P. Pregnancy management and successful outcome of Ehlers-Danlos syndrome type IV. Amer J Perinatol 1987; 4: 134-7.
111. Giangrande P. Pers comm, 1997.